• 原料直供
• 试剂商城
• 直接询价

分类

• {Chemicalbo
• {SNA} Anionic Detergents, Bile Salts, Bile acids and Derivatives, Cell Culture, Chemical ER Chaperones, Detergents N to Z, Detergents by Applications, Endoplasmic Reticulum Stress, Gene Regulation, Phototherapy, Sterol Lipids, 代谢组学, 代谢通路, 化学预防剂, 去垢剂, 抗肿瘤药物, 生化试剂, 癌症研究, 细胞信号转导和神经科学, 细胞生物学, 胆汁酸代谢, 脂类
• {SNA} Anionic Detergents, Antitumor Agents, Bile Acid Metabolism, Bile Salts, Bile acids and Derivatives,
• {SNA} Analytical Standards,
• {SNA} Anionic D

产品应用

• 阴离子去垢剂，用于生化研究。

相关文献及参考

• [2]. Kumar D, et al. Use of ursodeoxycholic acid in liver diseases. J Gastroenterol Hepatol. 2001 Jan;16(1):3-14.
• [3]. Biao Nie, et al. Specific Bile Acids Inhibit Hepatic Fatty Acid Uptake in Mice. Hepatology. 2012 Oct;56(4):1300-10.
• Merck: 14,9889
• Merck: 14,9889 Beilstein:10(3)1635
• [1]. Jackson H, et al. Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology. 2007 Oct;46(4):1131-7.
• [1]. Jackson H, et al. Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology. 2007 Oct;46(4):1131-7.
• [2]. Kumar D, et al. Use of ursodeoxycholic acid in liver diseases. J Gastroenterol Hepatol. 2001 Jan;16(1):3-14.
• [3]. Biao Nie, et al. Specific Bile Acids Inhibit Hepatic Fatty Acid Uptake in Mice. Hepatology. 2012 Oct;56(4):1300-10.

安全信息

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 1 gm/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   85IQAH "Modern Pharmaceuticals of Japan, IV," Tokyo, Japan Pharmaceutical,
   Medical and Dental Supply Exporters' Assoc., 1972  Volume(issue)/page/year:
   -,109,1972

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 310 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Behavioral - convulsions or effect on seizure threshold
REFERENCE :
   KSRNAM Kiso to Rinsho.  Clinical Report.  (Yubunsha Co., Ltd., 1-5, Kanda
   Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan)  V.1-    1960-
   Volume(issue)/page/year: 9,3159,1975

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 700 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   BCFAAI Bollettino Chimico Farmaceutico.  (Societa Editoriale Farmaceutica,
   Via Ausonio 12, 20123 Milan, Italy)  V.33-    1894- Volume(issue)/page/year:
   126,282,1987

TYPE OF TEST            : LD50 - Lethal dose, 5

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 4600 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   BCFAAI Bollettino Chimico Farmaceutico.  (Societa Editoriale Farmaceutica,
   Via Ausonio 12, 20123 Milan, Italy)  V.33-    1894- Volume(issue)/page/year:
   126,282,1987

{haza

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Yeast - Saccharomyces cerevisiae
DOSE/DURATION           : 51 mmol/L
REFERENCE :
   ARTODN Archives of Toxicology.  (Springer-Verlag, Heidelberger Pl. 3, D-1000
   Berlin 33, Fed. Rep. Ger.)  V.32-    1974-  Volume(issue)/page/year:
   60,192,1987

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Bacteria - Salmonella typhimurium
DOSE/DURATION           : 40 mg/L
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 158,45,1985

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 1200 mg/kg
SEX/DURATION            : female 9-14 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Maternal Effects - other effects
   Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
   e.g., stunted fetus)
REFERENCE :
   KSRNAM Kiso to Rinsho.  Clinical Report.  (Yubunsha Co., Ltd., 1-5, Kanda
   Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan)  V.1-    1960-
   Volume(issue)/page/year: 9

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rabbit
DOSE                    : 65 mg/kg
SEX/DURATION            : female 6-18

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 1200 mg/kg
SEX/DURATION            : female 7-12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Maternal Effects - other effects
REFERENCE :
   KSRNAM Kiso to Rinsho.  Clinical Report.  (Yubunsha Co., Ltd., 1-5, Kanda
   Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan)  V.1-    1960-
   Volume(issue)/page/year: 9,3223,1975

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 1200 mg/kg
SEX/DURATION            : female 9-14 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Maternal Effects - other effects
   Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
   e.g., stunted fetus)
REFERENCE :
   KSRNAM Kiso to Rinsho.  Clinical Report.  (Yubunsha Co., Ltd., 1-5, Kanda
   Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan)  V.1-    1960-
   Volume(issue)/page/year: 9,3223,

其他信息

• MSDS 信息:3alpha,7beta-Dihydroxy-6beta-cholan-24-oic acid(128-13-2).msds
• 上游原料:甲醇 --> 二乙二醇 --> 2,3-丁二酮 --> 铬酸钾 --> 鹅去氧胆酸 --> 5-Β-胆烷酸 --> 胆酸甲酯 --> 乙酰胆酸
• 味苦。易溶于乙醇、冰乙酸，微溶于氯仿、乙醚，几乎不溶于水。半数致死量1000mg/kg(大鼠，腹腔)、310mg/kg(大鼠，静脉)。
• 用途二:胆石溶解药。主要用于不宜手术治疗的胆固醇型胆结石，尤其是胆囊功能基本正常、结石直径在15mm以下、透X线、非钙化型的浮动胆固醇结石的治愈率高。对中毒性肝炎、胆囊炎、原发性硬化性胆管炎、原发性胆汁淤积性肝硬化也有一定的治疗效果。提高α-干扰素治疗慢性丙型肝炎的疗效。有腹泻，罕见便秘、过敏反应、瘙痒、头痛、头晕、胃痛、胰腺炎及心动过缓等。胆道完全阻塞和严重
• Acros Organics:熊果去氧胆酸/熊去氧胆酸 Ursodeoxycholic acid, 99%(128-13-2)
• 熊去氧胆酸价格(试剂
• 方法一:方法一、以鹅去氧胆酸为原料 3α, 7α-二乙酰胆酸甲酯的制备 取无水甲醇36ml，通入1g干燥氯化氢气体，加胆酸12g，搅拌，加热回流20-30min，室温放置数小时后析出晶体，冷冻，过滤，用乙醚洗涤，干燥，得胆酸甲酯。取胆酸甲酯2g，加苯9.6ml，加吡啶2.4ml，加乙酐2.4ml，振摇10-15min，室温放置20h，将反应液倒入100ml水中，除去苯层，反复用蒸馏水洗涤，回收溶剂，固体残渣用石油醚洗涤1次，用甲醇-水溶液重结晶，得3α，7α-二乙酰胆酸甲酯。 胆酸→胆酸甲酯→3α，7α-二乙酰胆酸甲酯 鹅去氧胆酸的制备 取二乙酰胆酸甲酯1.5g，加乙酸24 ml，加铬酸钾溶液(取铬酸钾0.76g溶于1.8ml水中)，加热至40℃，反应8h，加水120ml，振摇片刻，放置12h，过滤，用蒸馏水洗至中性，干燥，得3α，7α-二乙酰氧基- 12-酮基胆烷酸甲酯，简称12-酮。取12-酮15g，加二乙二醇醚150ml，加80%水合肼溶液15ml，加氢氧化钾15g，加热至30℃回流15h，升温至195-200℃，回流2.5h，升温至217℃反应片刻，冷却至190℃，加水合肼溶液0.7ml，在3h内由215℃升温至220℃，冷却，加蒸馏水600ml，加10%硫酸调pH 3，析出结晶，过滤，水洗至中性，加乙酸乙酯，弃去水层，有机层用水洗1-2次，减压蒸馏，得白色3α，7α-二羟基胆烷酸，即鹅去氧胆酸。 3α，7α-二乙酰胆酸甲酯→3α，7α-二乙酰氧基-12-酮基胆烷酸甲酯→3α，7α-二羟基胆烷酸（鹅去氧胆酸） 熊去氧胆酸精品的制备 取鹅去氧胆酸2g，加100ml乙酸，加乙酸钾20g，振摇溶解，加铬酸钾1.5g(溶于10ml水中)，室温放置过夜，加水200ml，析出结晶，过滤，水洗，干燥，得3α-羟基-7-酮基胆烷酸。取3α-羟基-7-酮基胆烷酸4g，加正丁醇100ml，加热至约115℃，分次加入金属钠8g，逐渐有白色浆状物析出，继续反应30min，加水120ml，搅拌升温溶解透明，减压蒸去有机层，残渣加水500ml，溶解，过滤，滤液加10%硫酸调pH3，有白色絮状物沉淀，过滤，水洗至中性，干燥，加乙酸乙酯洗涤，稀乙醇结晶，得3α，7β-二羟基胆烷酸，即熊去氧胆酸精品。 鹅去氧胆酸[铬酸钾]→3α-羟基-7-酮基胆酸[金属钠，115℃]→3α, 7β-二羟基胆烷酸（熊去氧胆酸） 方法二、以猪胆
• 参考质量标准:原料药 中国药典2000年版1006页 指标名称 指标 指标名称 指标 含量(C24H40O4)/% ≥98.5/干燥失重/% ≤1.0 比旋度(40mg/ml无水乙醇)/+59.0°-+62.0°/炽灼残渣/% ≤0.2 重金属 ≤百万分之二十 异臭/无/砷盐/% ≤0.0002 氯化物/% ≤0.02/硫酸盐/% ≤0.05 钡盐 无 片剂 中国药典2000年版1006页 指标名称 指标 指标名称 指标 含量(C24H40O4)/% 95.0-105.0/检查/符合片剂规定
• 熊去氧胆酸，主要成分是3a,7β- 二羟基-5β- 胆甾烷-24-酸，为有机化合物，无臭，味苦。本品在乙醇中易溶，在氯仿中不溶；在冰醋酸中易溶，在氢氧化钠试液中溶解。医学上用于增加胆汁酸分泌，并使胆汁成分改变，降低胆汁中胆固醇及胆固醇脂，有利于胆结石中的胆固醇逐渐溶解。